Literature DB >> 2926258

Staging in cholesteatoma surgery.

D F Austin.   

Abstract

Single stage surgery was used for 174 operations for cholesteatoma. The results were analysed using months at risk (actuarial) statistics. The methods of data collection and of creating a life-table for cholesteatoma follow-up are described. Ninety-one canal-down procedures are compared with 82 canal-up procedures as to the recidivism rate as well as hearing results. The actuarial tables showed a 50 per cent cumulative success rate for canal-up procedures versus a 90 per cent rate for canal-down operations. The successful canal-up procedures, however, demonstrated slightly better hearing results. These success rates seemed to be comparable to those using planned staged surgery. It was concluded that if single stage canal-up procedures were used with larger mastoids and canal-down procedures with smaller mastoids, 80 per cent of patients could be controlled without either residual or recurrent disease appearing. For the others, it was felt safe to wait for the disease to reappear rather than to do planned two-stage procedures for all patients. It was further urged that actuarial statistics be employed when reporting the results of surgery for cholesteatoma.

Entities:  

Mesh:

Year:  1989        PMID: 2926258     DOI: 10.1017/s002221510010831x

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Outcomes of Modified Canal Wall Down Mastoidectomy and Mastoid Obliteration Using Autologous Materials.

Authors:  Bo Gyung Kim; Hyo Jun Kim; Seung Jae Lee; Eunsang Lee; Se A Lee; Jong Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-01       Impact factor: 3.372

2.  Analysis of long-term anatomic results of radical mastoidectomy.

Authors:  Horia Mocanu; Adela-Ioana Mocanu; Gabriella Coadă; Alexandru Bonciu; Mihai-Adrian Schipor; Marian Rădulescu
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.